Novo CEO pressed by Senate to cut rates of being overweight, diabetic issues drugs CEO Lars Fruergaard Jørgensen told lawmakers the company would take into consideration new talks with insurers concerning the listing selling prices of Wegovy and copyright should they pledge to maintain the medicines on their own formularies. https://busch-light-peach-nutriti27161.pages10.com/the-smart-trick-of-healthcare-news-that-nobody-is-discussing-66183570